Physician profile
William B Lujan
NPI 1588644355
$7,982.37
in general payments reported to CMS, 2019-2025
21 companies · $1,905 in 2025
The $1,905 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,248 · 2020: $494 · 2021: $523 · 2022: $516 · 2023: $1,118 · 2024: $1,180 · 2025: $1,905.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,203.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,202.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,541.88 | 2021-2025 | |
| Amgen INC. | $821.34 | 2019-2020 | |
| Acadia Pharmaceuticals INC | $594.28 | 2023-2025 | Nuplazid |
| Biogen, INC. | $477.72 | 2019-2021 | |
| Otsuka America Pharmaceutical, INC. | $417.28 | 2025 | Rexulti |
| Lilly USA, LLC | $317.27 | 2019-2020 | |
| Genentech USA, INC. | $278.12 | 2019-2025 | Ocrevus, Ocrevus Zunovo |
| Teva Pharmaceuticals USA, INC. | $240.32 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $219.78 | 2021 | |
| Ucb, INC. | $200.86 | 2019 | |
| Acorda Therapeutics, INC | $125.00 | 2019 | |
| Eisai INC. | $123.07 | 2019 | |
| Novartis Pharmaceuticals Corporation | $121.83 | 2019 | |
| Alexion Pharmaceuticals, INC. | $121.83 | 2019 | |
| Genzyme Corporation | $114.94 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $111.66 | 2022 | |
| Allergan, INC. | $43.50 | 2020-2021 | |
| Janssen Biotech, INC. | $38.18 | 2025 | |
| Lundbeck LLC | $37.17 | 2025 | Vyepti, Rexulti |
| Jazz Pharmaceuticals INC. | $19.12 | 2025 | |
| Livanova USA, INC. | $17.22 | 2024 | Vns Therapy Sentiva Model 1000 Generator |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Lujan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.